(Q45858715)

17 December 2017

title

A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model (English)

1 reference

17 December 2017

1 reference

1 reference

3

1 reference

17 December 2017

Akseli Hemminki

1

object named as

Akseli Hemminki

1 reference

17 December 2017

13

David T Curiel

1 reference

17 December 2017

2

Anna Kanerva

1 reference

17 December 2017

12

Gene P Siegal

1 reference

17 December 2017

author name string

Gerd J Bauerschmitz

4

1 reference

17 December 2017

Bruce F Smith

5

1 reference

17 December 2017

Bin Liu

6

1 reference

17 December 2017

Minghui Wang

7

1 reference

17 December 2017

Renee A Desmond

8

1 reference

17 December 2017

Anne Keriel

9

1 reference

17 December 2017

Brian Barnett

10

1 reference

17 December 2017

Henry J Baker

11

1 reference

17 December 2017

publication date

1 February 2003

1 reference

17 December 2017

published in

Molecular Therapy

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

page(s)

163-173

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

Adenoviruses in oncology: a viable option?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Update on adenovirus and its vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Serum and ascites neutralizing antibodies in ovarian cancer patients treated with intraperitoneal adenoviral gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Productive replication of human adenoviruses in mouse epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Novel human gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Studies on the use of viruses in the treatment of carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Adenoviruses in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Disseminated adenovirus disease in immunocompromised and immunocompetent children

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Effects of macrophage depletion and anti-CD40 ligand on transgene expression and redosing with recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Trafficking and propagation of canine adenovirus vectors lacking a known integrin-interacting motif

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Characterization of cis-acting sequences involved in canine adenovirus packaging

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Osteocalcin gene promoter: Unlocking the secrets for regulation of osteoblast growth and differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Osteocalcin-directed gene therapy for prostate-cancer bone metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Identification of osteocalcin mRNA in nonosteoid tissue of rats and humans by reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2802%2900049-7

7 January 2021

10.1016/S1525-0016(02)00049-7

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

12597904

1 reference

17 December 2017